Patents by Inventor Gillian Cave

Gillian Cave has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Glyburide composition
    Patent number: 6830760
    Abstract: The present invention relates to a physical form of the known drug substance glyburide, also known as glibenclamide, and chemically defined as 5-chloro-N-[2-[4-[[[(cyclohexylamino)-carbonyl]amino]sulfonyl]phenyl]ethyl]-2-methoxybenzamide (Merck Index, Tenth Edition, p. 642), as well as to dosage forms, e.g., tablets and capsules, incorporating said physical form of glyburide.
    Type: Grant
    Filed: April 30, 2003
    Date of Patent: December 14, 2004
    Assignee: Bristol-Myers Squibb Company
    Inventors: Gillian Cave, Sarah J. Nicholson
  • Glyburidge composition
    Publication number: 20030185880
    Abstract: The present invention relates to a physical form of the known drug substance glyburide, also known as glibenclarnide, and chemically defined as 5-chloro-N-[2-[4-[[[(cyclohexylamino)-carbonyl]amino]sulfonyl]phenyl]ethyl]-2-methoxybenzamide (Merck Index, Tenth Edition, p. 642), as well as to dosage forms, e.g., tablets and capsules, incorporating said physical form of glyburide.
    Type: Application
    Filed: April 30, 2003
    Publication date: October 2, 2003
    Inventors: Gillian Cave, Sarah J. Nicholson
  • Glyburide composition
    Publication number: 20010036479
    Abstract: The present invention relates to a physical form of the known drug substance glyburide, also known as glibenclamide, and chemically defined as 5-chloro-N-[2-[4-[[[(cyclohexylamino)-carbonyl]amino]sulfonyl]phenyl]ethyl]-2-methoxybenzamide (Merck Index, Tenth Edition, p. 642), as well as to dosage forms, e.g., tablets and capsules, incorporating said physical form of glyburide.
    Type: Application
    Filed: December 11, 2000
    Publication date: November 1, 2001
    Inventors: Gillian Cave, Sarah J. Nicholson
  • Solid oral dosage form comprising a combination of metformin and glibenclamide
    Patent number: 6303146
    Abstract: The present invention relates to a solid oral dosage form comprising a combination of metformin and glibenclamide in which the size of glibenclamide is such that the glibenclamide bioavailability is comparable to the glibenclamide bioavailability obtained with a separate administration of metformin and glibenclamide.
    Type: Grant
    Filed: July 14, 1999
    Date of Patent: October 16, 2001
    Assignee: LIPHA
    Inventors: Yves Bonhomme, Geoffrey Nicholson, Gillian Cave, Sarah J. Nicholson
  • Solid oral dosage form comprising a combination of metformin and glibenclamide
    Patent number: RE38629
    Abstract: The present invention relates to a solid oral dosage form comprising a combination of metformin and glibenclamide in which the size of glibenclamide is such that the glibenclamide bioavailability is comparable to the glibenclamide bioavailability obtained with a separate administration of metformin and glibenclamide.
    Type: Grant
    Filed: December 27, 2002
    Date of Patent: October 19, 2004
    Assignee: Merck Sante
    Inventors: Yves Bonhomme, Geoffrey Nicholson, Gillian Cave, Sarah J. Nicholson